Mitsubishi Chemical Group. Science. Value. Life.
Explore Our Treatments

One Scientific Breakthrough Can Change Countless Lives

In pursuit of the impossible

Watch Now

We believe in helping people who are struggling with serious and debilitating diseases.

Learn More About Us
SCIENCE
Delivering On
Unmet Needs

Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses.

Learn About Our Work
AMYOTROPHIC LATERAL SCLEROSIS
Our Relentless Commitment

Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs.

Learn more about ALS
News

Important news about our latest developments in science & medicine.

See All
Apr 20, 2023
Mitsubishi Tanabe Pharma America to Present Latest Findings Across ALS and Parkinson’s Disease at 2023 American Academy of Neurology Annual Meeting Read More
Apr 03, 2023
Mitsubishi Tanabe Pharma America, Inc. Announces Reorganization and Appoints New Leadership Read More
Mar 23, 2023
Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Read More
Mar 20, 2023
Mitsubishi Tanabe Pharma America to Share ALS Research at AMCP Annual Meeting 2023 Read More
Mar 17, 2023
Mitsubishi Tanabe Pharma America Announces Presentations in ALS at 2023 MDA Clinical & Scientific Conference Read More
Mar 16, 2023
Mitsubishi Tanabe Pharma America Announces More Than 10,000 People with ALS Treated with RADICAVA ORS® (edaravone) and/or RADICAVA® (edaravone) Read More
You are leaving this website, hosted by Mitsubishi Tanabe Pharma America, Inc.
This link will take you to a website to which our Privacy Policy and Terms of Use does not apply. Mitsubishi Tanabe Pharma America, Inc. does not control the content of this third-party site.
Continue
Cancel